Millipore Sigma Vibrant Logo

Parteck® Functional Excipients

Tableting formulationWhen you design a solid dosage form, there are many factors to consider: the active ingredient, bioavailability enhancement, release kinetics, specific dosage, packaging, shelf life, and more. Our Parteck® excipients were designed with the formulator’s challenges in mind and are particle optimized for excellent performance in formulation development and manufacture. Backed by the Emprove® program with its stringent quality control, as well as regulatory support and documentation, Parteck® excipients help to speed up your approval processes.
Flexible Tableting
  • High tablet hardness at low compression forces, providing tablet robustness and rapid disintegration
  • High and low API dosages enabled by the unique particle surface
  • Specialized excipients for direct compression, wet and dry granulation, film coating, lubrication, and rapid disintegration
Optimized Drug Delivery
  • Options for modifying release kinetics, such as orally disintegrating tablets and sustained-release solid oral formulations
  • Specialized excipients for different routes of administration, including dry powder inhalation
Enhanced Solubility
Specialized excipients that boost the efficacy of your final drug product by enhancing API solubility through the use of polyvinyl alcohol for hot melt extrusion, or a silica drug carrier with a unique surface structure.
To find out more about our Parteck®product range please visit the links below:

The Parteck® Game: Release the API. Play game now!

The Parteck® Game
Release the API

Play Game!
Webinar: Hot Melt Extrusion with PVA: Overcoming Solubility and Bioavailability Challenges

Hot Melt Extrusion with PVA: Overcoming Solubility and Bioavailability Challenges

Watch Now

Recent News

26 Oct 2015
Merck Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations

Merck today introduced Parteck® SRP 80, a new functional excipient for oral sustained-release formulations.

20151026 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
View All News